SREBP1 upregulates FA and TG synthesis and is activated in NAFLD due to high glucose levels, IR, and oxidative stress [86,87,88,89,90,91,92]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.